生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | KT-276 is a derivative of PKT-185, designed as an orally available and selective inhibitor targeting the nuclear export (SINE) function. Specifically, it acts as a CRM1 antagonist, irreversibly binding to and inhibiting the CRM1 protein, which plays a crucial role in the nuclear export of numerous proteins and RNA[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.35mL 0.47mL 0.23mL |
11.73mL 2.35mL 1.17mL |
23.46mL 4.69mL 2.35mL |
参考文献 |
---|